- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammatory Targets in Diabetic Nephropathy
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 2, Pages 458
Publisher
MDPI AG
Online
2020-02-08
DOI
10.3390/jcm9020458
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications
- (2019) Elisa Dal Canto et al. European Journal of Preventive Cardiology
- The effect of dapagliflozin treatment on epicardial adipose tissue volume
- (2018) Takao Sato et al. Cardiovascular Diabetology
- The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
- (2018) Keizo Kanasaki CLINICAL SCIENCE
- Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease
- (2018) Juan F. Navarro-González et al. DIABETES CARE
- Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats
- (2018) Krit Jaikumkao et al. DIABETES OBESITY & METABOLISM
- The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
- (2018) Merlin C. Thomas et al. DIABETOLOGIA
- Anti-Inflammatory Action of Sitagliptin and Linagliptin in Doxorubicin Nephropathy
- (2018) Chor Ho Jo et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes
- (2018) W. Timothy Garvey et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
- (2018) Katherine R Tuttle et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Albumin downregulates Klotho in tubular cells
- (2018) Beatriz Fernandez-Fernandez et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
- (2018) Arpeeta Sharma et al. Frontiers in Physiology
- Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
- (2018) Vlado Perkovic et al. Lancet Diabetes & Endocrinology
- Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease
- (2018) Bancha Satirapoj et al. BMC Nephrology
- Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms
- (2018) Iolanda Lazaro et al. Frontiers in Pharmacology
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Targeting inflammation in diabetic nephropathy: a tale of hope
- (2018) Juan Antonio Moreno et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
- (2017) Mihoko Matsumura et al. Diabetes Therapy
- Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
- (2017) Mihoko Matsumura et al. Diabetes Therapy
- Reduction in cardiovascular and all-cause mortality in the EMPA-REG OUTCOME trial: A critical analysis
- (2016) André J. Scheen DIABETES & METABOLISM
- Tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, suppresses renal damage in KKAy/Ta mice, obese and type 2 diabetic animals
- (2016) Yuji Ishibashi et al. Diabetes & Vascular Disease Research
- The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet
- (2016) Ji Hye Han et al. DIABETOLOGIA
- Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition
- (2016) Volker Vallon et al. DIABETOLOGIA
- Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients
- (2016) Sang Soo Kim et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Myrciaria cauliflora extract improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-nicotinamide mice
- (2016) Jeng-Dong Hsu et al. JOURNAL OF FOOD AND DRUG ANALYSIS
- C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria
- (2016) Jan Menne et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in Levels of Biomarkers Associated with Adipocyte Function and Insulin and Glucagon Kinetics During Treatment with Dapagliflozin Among Obese Type 2 Diabetes Mellitus Patients
- (2016) Aki Okamoto et al. Drugs in research & development
- Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
- (2016) Eri H. Kobayashi et al. Nature Communications
- Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy
- (2015) Huei-Fen Jheng et al. Disease Models & Mechanisms
- Tofogliflozin, A Highly Selective Inhibitor of SGLT2 Blocks Proinflammatory and Proapoptotic Effects of Glucose Overload on Proximal Tubular Cells Partly by Suppressing Oxidative Stress Generation
- (2015) Y. Ishibashi et al. HORMONE AND METABOLIC RESEARCH
- Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis
- (2015) Mao-Lu Tian et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase
- (2015) Francisca Adilfa de Oliveira Garcia et al. Journal of Inflammation-London
- Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
- (2015) Khurrum Shahzad et al. KIDNEY INTERNATIONAL
- Efficacy and Safety of Tangshen Formula on Patients with Type 2 Diabetic Kidney Disease: A Multicenter Double-Blinded Randomized Placebo-Controlled Trial
- (2015) Ping Li et al. PLoS One
- Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
- (2015) Stephanie Toth-Manikowski et al. Journal of Diabetes Research
- Inflammatory Cytokines in Diabetic Nephropathy
- (2015) Javier Donate-Correa et al. Journal of Diabetes Research
- Association of plasma soluble α-klotho with pro-endothelin-1 in patients with type 2 diabetes
- (2014) Jian-Jun Liu et al. ATHEROSCLEROSIS
- Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
- (2014) Bowen Lin et al. Cardiovascular Diabetology
- The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin
- (2014) Can Wu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of the Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist Dulaglutide on Ambulatory Blood Pressure and Heart Rate in Patients With Type 2 Diabetes Mellitus
- (2014) Keith C. Ferdinand et al. HYPERTENSION
- Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease: The PREDIAN Trial
- (2014) J. F. Navarro-Gonzalez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Therapeutic approaches to diabetic nephropathy—beyond the RAS
- (2014) Beatriz Fernandez-Fernandez et al. Nature Reviews Nephrology
- Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
- (2014) Naoto Terami et al. PLoS One
- Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors
- (2013) M. Barbieri et al. ATHEROSCLEROSIS
- Efficacy of alogliptin, a dipeptidyl peptidase-4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE) - receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes
- (2013) Koji Sakata et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α
- (2013) Keiichiro Matoba et al. KIDNEY INTERNATIONAL
- Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice
- (2013) S. J. Seok et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?
- (2013) Usha Panchapakesan et al. PLoS One
- Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition
- (2012) Swenja Kröller-Schön et al. CARDIOVASCULAR RESEARCH
- Inflammation and the pathogenesis of diabetic nephropathy
- (2012) Jun Wada et al. CLINICAL SCIENCE
- Effects of pentoxifylline on inflammatory parameters in chronic kidney disease patients: a randomized trial
- (2012) Marian Goicoechea et al. JOURNAL OF NEPHROLOGY
- Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion
- (2012) Osamu Asai et al. KIDNEY INTERNATIONAL
- Treating diabetic nephropathy—still an unresolved issue
- (2012) Mark E. Cooper Nature Reviews Endocrinology
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Knockout of Toll-Like Receptor-2 Attenuates Both the Proinflammatory State of Diabetes and Incipient Diabetic Nephropathy
- (2011) Sridevi Devaraj et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK/NF-κB signaling pathway activation in vascular endothelial cells
- (2011) Daiji Kawanami et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
- (2011) Hongting Zheng et al. DIABETES
- Klotho Depletion Contributes to Increased Inflammation in Kidney of the db/db Mouse Model of Diabetes via RelA (Serine)536 Phosphorylation
- (2011) Y. Zhao et al. DIABETES
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
- (2011) R. Kodera et al. DIABETOLOGIA
- SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes Mellitus
- (2011) Raktim Kumar Ghosh et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Inflammatory Cytokines TWEAK and TNF Reduce Renal Klotho Expression through NF B
- (2011) J. A. Moreno et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pyridorin in Type 2 Diabetic Nephropathy
- (2011) E. J. Lewis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy
- (2011) D. K. Packham et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes
- (2011) Sufyan G. Sayyed et al. KIDNEY INTERNATIONAL
- Cellular and molecular mechanisms of renal fibrosis
- (2011) Youhua Liu Nature Reviews Nephrology
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
- (2011) Juan F. Navarro-González et al. Nature Reviews Nephrology
- Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
- (2011) Pablo E. Pergola et al. NEW ENGLAND JOURNAL OF MEDICINE
- Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy
- (2011) Vivian Soetikno et al. Nutrition & Metabolism
- Cilostazol Ameliorates Nephropathy in Type 1 Diabetic Rats Involving Improvement in Oxidative Stress and Regulation of TGF-β and NF-κB
- (2010) Wen-Chin LEE et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise: A randomized, double-blind, placebo-controlled, phase 3 trial
- (2010) E. Ferrannini et al. DIABETES CARE
- Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury
- (2010) A. K. H. Lim et al. DIABETOLOGIA
- Sitagliptin reduces albuminuria in patients with type 2 diabetes [Rapid Communication]
- (2010) Sachiko Hattori ENDOCRINE JOURNAL
- Rho Kinase-2 Activation in Human Endothelial Cells Drives Lysophosphatidic Acid-mediated Expression of Cell Adhesion Molecules via NF-κB p65
- (2010) Hideaki Shimada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NF- B in Renal Inflammation
- (2010) A. B. Sanz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy
- (2010) G. Ortiz-Munoz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Diabetic kidney disease: act now or pay later
- (2010) Robert C. Atkins et al. KIDNEY INTERNATIONAL
- The RAAS in the pathogenesis and treatment of diabetic nephropathy
- (2010) Piero Ruggenenti et al. Nature Reviews Nephrology
- Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice
- (2009) A. K. H. Lim et al. DIABETOLOGIA
- Effect of Pentoxifylline in Addition to Losartan on Proteinuria and GFR in CKD: A 12-Month Randomized Trial
- (2008) Shuei-Liong Lin et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The Effect of Pentoxifylline on Proteinuria in Diabetic Kidney Disease: A Meta-analysis
- (2008) Brendan B. McCormick et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Late Onset of Ccl2 Blockade with the Spiegelmer mNOX-E36–3′PEG Prevents Glomerulosclerosis and Improves Glomerular Filtration Rate in db/db Mice
- (2008) Volha Ninichuk et al. AMERICAN JOURNAL OF PATHOLOGY
- Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
- (2008) C. C. Berthier et al. DIABETES
- Upregulated IL-18 expression in type 2 diabetic subjects with nephropathy: TGF-β1 enhanced IL-18 expression in human renal proximal tubular epithelial cells
- (2008) Kazunari Miyauchi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The Role of Inflammatory Cytokines in Diabetic Nephropathy
- (2008) J. F. Navarro-Gonzalez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
- (2008) G. J. Ko et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Defining human diabetic nephropathy on the molecular level: Integration of transcriptomic profiles with biological knowledge
- (2008) Sebastian Martini et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease—A randomized placebo-controlled study
- (2006) Juliano Lara Fernandes et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search